• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预处理CT图像中的迁移学习方法用于预测晚期恶性胸膜间皮瘤的治疗反应。

Transfer learning approach in pre-treatment CT images to predict therapeutic response in advanced malignant pleural mesothelioma.

作者信息

Fanizzi Annarita, Catino Annamaria, Bove Samantha, Comes Maria Colomba, Montrone Michele, Sicolo Angela, Signorile Rahel, Perrotti Pia, Pizzutilo Pamela, Galetta Domenico, Massafra Raffaella

机构信息

Laboratorio di Biostatistica e Bioinformatica, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

Struttura Semplice Dipartimentale di Oncologia Medica Toracica, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

出版信息

Front Oncol. 2024 Sep 16;14:1432188. doi: 10.3389/fonc.2024.1432188. eCollection 2024.

DOI:10.3389/fonc.2024.1432188
PMID:39351354
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11439621/
Abstract

INTRODUCTION

Malignant pleural mesothelioma (MPM) is a poor-prognosis disease. Owing to the recent availability of new therapeutic options, there is a need to better assess prognosis. The initial clinical response could represent a useful parameter.

METHODS

We proposed a transfer learning approach to predict an initial treatment response starting from baseline CT scans of patients with advanced/unresectable MPM undergoing first-line systemic therapy. The therapeutic response has been assessed according to the mRECIST criteria by CT scan at baseline and after two to three treatment cycles. We used three slices of baseline CT scan as input to the pre-trained convolutional neural network as a radiomic feature extractor. We identified a feature subset through a double feature selection procedure to train a binary SVM classifier to discriminate responders (partial response) from non-responders (stable or disease progression).

RESULTS

The performance of the prediction classifiers was evaluated with an 80:20 hold-out validation scheme. We have evaluated how the developed model was robust to variations in the slices selected by the radiologist. In our dataset, 25 patients showed an initial partial response, whereas 13 patients showed progressive or stable disease. On the independent test, the proposed model achieved a median AUC and accuracy of 86.67% and 87.50%, respectively.

CONCLUSIONS

The proposed model has shown high performance even by varying the reference slices. Novel tools could help to improve the prognostic assessment of patients with MPM and to better identify subgroups of patients with different therapeutic responsiveness.

摘要

引言

恶性胸膜间皮瘤(MPM)是一种预后较差的疾病。由于最近出现了新的治疗选择,因此有必要更好地评估预后。初始临床反应可能是一个有用的参数。

方法

我们提出了一种迁移学习方法,用于从接受一线全身治疗的晚期/不可切除MPM患者的基线CT扫描预测初始治疗反应。根据mRECIST标准,在基线和两到三个治疗周期后通过CT扫描评估治疗反应。我们使用基线CT扫描的三层切片作为预训练卷积神经网络的输入,该网络作为放射组学特征提取器。我们通过双重特征选择程序确定一个特征子集,以训练二元支持向量机分类器,区分反应者(部分缓解)和无反应者(病情稳定或进展)。

结果

使用80:20留出验证方案评估预测分类器的性能。我们评估了所开发模型对放射科医生选择的切片变化的稳健性。在我们的数据集中,25例患者显示初始部分缓解,而13例患者显示病情进展或稳定。在独立测试中,所提出的模型分别实现了86.67%的中位数AUC和87.50%的准确率。

结论

即使改变参考切片,所提出的模型也显示出高性能。新型工具有助于改善MPM患者的预后评估,并更好地识别具有不同治疗反应性的患者亚组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24bb/11439621/527ed3622dec/fonc-14-1432188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24bb/11439621/8ab9c821d1d4/fonc-14-1432188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24bb/11439621/527ed3622dec/fonc-14-1432188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24bb/11439621/8ab9c821d1d4/fonc-14-1432188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24bb/11439621/527ed3622dec/fonc-14-1432188-g002.jpg

相似文献

1
Transfer learning approach in pre-treatment CT images to predict therapeutic response in advanced malignant pleural mesothelioma.预处理CT图像中的迁移学习方法用于预测晚期恶性胸膜间皮瘤的治疗反应。
Front Oncol. 2024 Sep 16;14:1432188. doi: 10.3389/fonc.2024.1432188. eCollection 2024.
2
Informative Power Evaluation of Clinical Parameters to Predict Initial Therapeutic Response in Patients with Advanced Pleural Mesothelioma: A Machine Learning Approach.评估临床参数对晚期胸膜间皮瘤患者初始治疗反应的预测信息能力:一种机器学习方法。
J Clin Med. 2022 Mar 16;11(6):1659. doi: 10.3390/jcm11061659.
3
Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.在评估恶性胸膜间皮瘤对铂类双联化疗的反应时,18F-FDG-PET/CT代谢反应评估优于改良RECIST标准。
Eur J Radiol. 2017 Jan;86:92-98. doi: 10.1016/j.ejrad.2016.11.009. Epub 2016 Nov 5.
4
Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma.评估不可切除恶性胸膜间皮瘤患者纳武利尤单抗联合伊匹单抗治疗反应及预后预测的 FDG-PET/CT 与 CT 比较。
Oncotarget. 2024 Jun 20;15:408-417. doi: 10.18632/oncotarget.28594.
5
F-FDG PET/CT in therapy response and in predicting responders or non-responders in malignant pleural mesothelioma patients, by using semi-quantitative mRECIST and EORTC criteria.利用半定量mRECIST和欧洲癌症研究与治疗组织(EORTC)标准,F-FDG PET/CT在恶性胸膜间皮瘤患者的治疗反应及预测反应者或无反应者中的应用。
Hell J Nucl Med. 2018 Sep-Dec;21(3):191-197. doi: 10.1967/s002449910904. Epub 2018 Nov 10.
6
Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT.继续培美曲塞和铂类化疗治疗恶性胸膜间皮瘤(MPM):18F-FDG-PET/CT 的价值。
Eur J Radiol. 2012 Jan;81(1):e19-25. doi: 10.1016/j.ejrad.2010.11.006. Epub 2010 Dec 3.
7
Comparison of modified Response Evaluation Criteria in Solid Tumors, European Organization for Research and Treatment of Cancer criteria, and PET Response Criteria in Solid Tumors for evaluation of tumor response to chemotherapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma.比较改良实体瘤反应评价标准、欧洲癌症研究与治疗组织标准和实体瘤 PET 反应评价标准,用于评估不可切除恶性胸膜间皮瘤患者化疗的肿瘤反应和预后预测。
Nucl Med Commun. 2020 Aug;41(8):790-799. doi: 10.1097/MNM.0000000000001223.
8
Analysis of Cross-Combinations of Feature Selection and Machine-Learning Classification Methods Based on [F]F-FDG PET/CT Radiomic Features for Metabolic Response Prediction of Metastatic Breast Cancer Lesions.基于[F]F-FDG PET/CT影像组学特征的特征选择与机器学习分类方法交叉组合用于转移性乳腺癌病灶代谢反应预测的分析
Cancers (Basel). 2022 Jun 14;14(12):2922. doi: 10.3390/cancers14122922.
9
Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria.深度学习人工智能全自动测量恶性胸膜间皮瘤体积:与改良 RECIST 反应标准的验证和比较。
Thorax. 2022 Dec;77(12):1251-1259. doi: 10.1136/thoraxjnl-2021-217808. Epub 2022 Feb 2.
10
Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma.在恶性胸膜间皮瘤患者中,进行基线和中期PET评估的定量分析,以进行疗效评估和结果定义。
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):667-75. doi: 10.1007/s00259-014-2960-y. Epub 2014 Nov 18.

引用本文的文献

1
Integrating Radiogenomics and Machine Learning in Musculoskeletal Oncology Care.将放射基因组学与机器学习整合于肌肉骨骼肿瘤护理中。
Diagnostics (Basel). 2025 May 29;15(11):1377. doi: 10.3390/diagnostics15111377.

本文引用的文献

1
Explainable prediction model for the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma using CNN on CT images.基于 CT 图像的卷积神经网络对口腔鳞状细胞癌患者人乳头瘤病毒状态的可解释预测模型。
Sci Rep. 2024 Jun 20;14(1):14276. doi: 10.1038/s41598-024-65240-9.
2
Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma.抗 PD-L1/PD-1 单抗联合化疗作为不可切除性胸膜间皮瘤一线治疗的 Meta 分析
J Thorac Oncol. 2024 Jan;19(1):166-172. doi: 10.1016/j.jtho.2023.08.004. Epub 2023 Aug 9.
3
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma.
国际肺癌研究协会胸膜间皮瘤分期项目:胸膜间皮瘤预后因素的更新模型。
J Thorac Oncol. 2023 Dec;18(12):1689-1702. doi: 10.1016/j.jtho.2023.08.005. Epub 2023 Aug 9.
4
Malignant pleural mesothelioma characteristics and outcomes: A SEER-Medicare analysis.恶性胸膜间皮瘤的特征和结局:一项 SEER-Medicare 分析。
J Surg Oncol. 2023 Jul;128(1):134-141. doi: 10.1002/jso.27243. Epub 2023 Mar 18.
5
Survey of explainable artificial intelligence techniques for biomedical imaging with deep neural networks.基于深度神经网络的生物医学成像可解释人工智能技术综述。
Comput Biol Med. 2023 Apr;156:106668. doi: 10.1016/j.compbiomed.2023.106668. Epub 2023 Feb 18.
6
Asbestos Consumption and Malignant Mesothelioma Mortality Trends in the Major User Countries.主要石棉使用国的石棉消费与间皮瘤死亡率趋势
Ann Glob Health. 2023 Feb 13;89(1):11. doi: 10.5334/aogh.4012. eCollection 2023.
7
Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress.免疫检查点抑制剂免疫疗法与恶性间皮瘤的预测生物标志物:仍在进行中的工作。
Front Immunol. 2023 Jan 27;14:1121557. doi: 10.3389/fimmu.2023.1121557. eCollection 2023.
8
A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC.一种用于预测 NSCLC 中程序性细胞死亡蛋白或配体-1 抑制免疫治疗的治疗反应和肺毒性的新型放射组学生物标志物。
J Thorac Oncol. 2023 Jun;18(6):718-730. doi: 10.1016/j.jtho.2023.01.089. Epub 2023 Feb 10.
9
Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group.恶性胸膜间皮瘤影像学检查的考量:国际间皮瘤利益集团的共识声明
J Thorac Oncol. 2023 Mar;18(3):278-298. doi: 10.1016/j.jtho.2022.11.018. Epub 2022 Dec 20.
10
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients.基于全切片图像的深度学习模型预测皮肤黑素瘤患者无病生存。
Sci Rep. 2022 Nov 27;12(1):20366. doi: 10.1038/s41598-022-24315-1.